Capital Performance Advisors »

Ultragenyx Pharmaceutical shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $107k 1.9k 55.55

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Sands Capital Management
State Street Corporation
T. Rowe Price Associates
Wellington Management Company
ClearBridge Advisors
Federated Investors
Rtw Investments
Rock Springs Capital Management
Invesco
Deutsche Bank Aktiengesellschaft
Alkeon Capital Management
Alliancebernstein
Baker Bros. Advisors

View all funds holding Ultragenyx Pharmaceutical